Format
Sort by
Items per page

Send to

Choose Destination

Best matches for multiple sclerosis microbiome:

Gut microbiome and multiple sclerosis. Bhargava P et al. Curr Neurol Neurosci Rep. (2014)

Gut microbiota in multiple sclerosis: possible influence of immunomodulators. Cantarel BL et al. J Investig Med. (2015)

Advances in the immunopathogenesis of multiple sclerosis. Yadav SK et al. Curr Opin Neurol. (2015)

Search results

Items: 1 to 20 of 233

1.

Dietary non-fermentable fiber prevents autoimmune neurological disease by changing gut metabolic and immune status.

Berer K, Martínez I, Walker A, Kunkel B, Schmitt-Kopplin P, Walter J, Krishnamoorthy G.

Sci Rep. 2018 Jul 11;8(1):10431. doi: 10.1038/s41598-018-28839-3.

2.

Sodium chloride triggers Th17 mediated autoimmunity.

Haase S, Wilck N, Kleinewietfeld M, Müller DN, Linker RA.

J Neuroimmunol. 2018 Jun 30. pii: S0165-5728(17)30512-X. doi: 10.1016/j.jneuroim.2018.06.016. [Epub ahead of print] Review.

PMID:
29983198
3.

The influence of interferon β-1b on gut microbiota composition in patients with multiple sclerosis.

Castillo-Álvarez F, Pérez-Matute P, Oteo JA, Marzo-Sola ME.

Neurologia. 2018 Jun 9. pii: S0213-4853(18)30158-0. doi: 10.1016/j.nrl.2018.04.006. [Epub ahead of print] English, Spanish.

4.

Nutritional modulation of the intestinal microbiota: future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.

Lombardi VC, De Meirleir KL, Subramanian K, Nourani SM, Dagda RK, Delaney SL, Palotás A.

J Nutr Biochem. 2018 Apr 19;61:1-16. doi: 10.1016/j.jnutbio.2018.04.004. [Epub ahead of print] Review.

PMID:
29886183
5.

Altered Gut Microbiota in HIV Infection: Future Perspective of Fecal Microbiota Transplantation Therapy.

Kang Y, Cai Y.

AIDS Res Hum Retroviruses. 2018 Jul 9. doi: 10.1089/AID.2017.0268. [Epub ahead of print]

PMID:
29877092
6.

Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota.

Cignarella F, Cantoni C, Ghezzi L, Salter A, Dorsett Y, Chen L, Phillips D, Weinstock GM, Fontana L, Cross AH, Zhou Y, Piccio L.

Cell Metab. 2018 Jun 5;27(6):1222-1235.e6. doi: 10.1016/j.cmet.2018.05.006.

PMID:
29874567
7.

The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.

Camara-Lemarroy CR, Metz L, Meddings JB, Sharkey KA, Wee Yong V.

Brain. 2018 Jul 1;141(7):1900-1916. doi: 10.1093/brain/awy131.

PMID:
29860380
8.

Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases.

Gerhardt S, Mohajeri MH.

Nutrients. 2018 Jun 1;10(6). pii: E708. doi: 10.3390/nu10060708. Review.

9.

Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.

Chu F, Shi M, Lang Y, Shen D, Jin T, Zhu J, Cui L.

Mediators Inflamm. 2018 Apr 2;2018:8168717. doi: 10.1155/2018/8168717. eCollection 2018. Review.

10.

Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?

Pellegrini C, Antonioli L, Colucci R, Blandizzi C, Fornai M.

Acta Neuropathol. 2018 May 24. doi: 10.1007/s00401-018-1856-5. [Epub ahead of print] Review.

PMID:
29797112
11.

Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.

Stanisavljević S, Dinić M, Jevtić B, Đedović N, Momčilović M, Đokić J, Golić N, Mostarica Stojković M, Miljković Đ.

Front Immunol. 2018 May 2;9:942. doi: 10.3389/fimmu.2018.00942. eCollection 2018.

12.

Environmental factors in the development of multiple sclerosis.

Michel L.

Rev Neurol (Paris). 2018 Jun;174(6):372-377. doi: 10.1016/j.neurol.2018.03.010. Epub 2018 May 4. Review.

PMID:
29735167
13.

The protective effect of extra-virgin olive oil in the experimental model of multiple sclerosis in the rat.

Conde C, Escribano BM, Luque E, Aguilar-Luque M, Feijóo M, Ochoa JJ, LaTorre M, Giraldo AI, Lillo R, Agüera E, Santamaría A, Túnez I.

Nutr Neurosci. 2018 May 5:1-12. doi: 10.1080/1028415X.2018.1469281. [Epub ahead of print]

PMID:
29730972
14.

The microbiome and autoimmunity: a paradigm from the gut-liver axis.

Li B, Selmi C, Tang R, Gershwin ME, Ma X.

Cell Mol Immunol. 2018 Apr 30. doi: 10.1038/cmi.2018.7. [Epub ahead of print] Review.

PMID:
29706647
15.

A probiotic modulates the microbiome and immunity in multiple sclerosis.

Tankou SK, Regev K, Healy BC, Tjon E, Laghi L, Cox LM, Kivisäkk P, Pierre IV, Hrishikesh L, Gandhi R, Cook S, Glanz B, Stankiewicz J, Weiner HL.

Ann Neurol. 2018 Apr 20. doi: 10.1002/ana.25244. [Epub ahead of print]

PMID:
29679417
16.

Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall-King Hypothesis.

Laurence M, Asquith M, Rosenbaum JT.

Front Med (Lausanne). 2018 Apr 5;5:80. doi: 10.3389/fmed.2018.00080. eCollection 2018.

17.

Impacts of microbiome metabolites on immune regulation and autoimmunity.

Haase S, Haghikia A, Wilck N, Müller DN, Linker RA.

Immunology. 2018 Jun;154(2):230-238. doi: 10.1111/imm.12933. Epub 2018 Apr 30. Review.

PMID:
29637999
18.

The Role for Exosomal microRNAs in Disruption of Regulatory T Cell Homeostasis in Multiple Sclerosis.

Kimura K, Hohjoh H, Yamamura T.

J Exp Neurosci. 2018 Mar 26;12:1179069518764892. doi: 10.1177/1179069518764892. eCollection 2018.

19.

Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases.

Opazo MC, Ortega-Rocha EM, Coronado-Arrázola I, Bonifaz LC, Boudin H, Neunlist M, Bueno SM, Kalergis AM, Riedel CA.

Front Microbiol. 2018 Mar 12;9:432. doi: 10.3389/fmicb.2018.00432. eCollection 2018. Review.

20.

Interrelation of Diet, Gut Microbiome, and Autoantibody Production.

Petta I, Fraussen J, Somers V, Kleinewietfeld M.

Front Immunol. 2018 Mar 6;9:439. doi: 10.3389/fimmu.2018.00439. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center